Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Madeleine Duvic, Ann G. Martin, Elise A. Olsen, David P. Fivenson & H. Miles Prince. (2013) Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma. Leukemia & Lymphoma 54:3, pages 514-519.
Read now
Read now
H. Miles Prince, Ann G. Martin, Elise A. Olsen, David P. Fivenson & Madeleine Duvic. (2013) Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome. Leukemia & Lymphoma 54:1, pages 69-75.
Read now
Read now
Gwang Lee, Sang Seop Lee, Kwang Yol Kay, Dong Wan Kim, Sangdun Choi & Hong Ki Jun. (2009) Isolation and characterization of a novel adenosine deaminase inhibitor, IADA-7, from Bacillus sp. J-89. Journal of Enzyme Inhibition and Medicinal Chemistry 24:1, pages 59-64.
Read now
Read now
Articles from other publishers (18)
Matthew R. Kudelka, Jeffrey M. Switchenko, Mary Jo Lechowicz, Natia Esiashvili, Christopher R. Flowers, Mohammad K. Khan & Pamela B. Allen. (2020) Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy. Clinical Lymphoma Myeloma and Leukemia 20:11, pages 757-767.e3.
Crossref
Crossref
Lucie Heinzerling, Anke Hartmann & Martina HundLucie Heinzerling, Anke Hartmann & Martina Hund. 2019. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie
135
190
.
Wojciech Gorczyca. 2017. Flow Cytometry in Neoplastic Hematology. Flow Cytometry in Neoplastic Hematology
240
301
.
Hirozumi Sano, Ryoji Kobayashi, Junji Tanaka, Satoshi Hashino, Shuichi Ota, Yoshihiro Torimoto, Yasutaka Kakinoki, Satoshi Yamamoto, Mitsutoshi Kurosawa, Naoki Hatakeyama, Yoshihito Haseyama, Hajime Sakai, Kazuya Sato & Takashi Fukuhara. (2014) Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study. British Journal of Haematology 165:6, pages 786-792.
Crossref
Crossref
Lucie Heinzerling, Anke Hartmann, Martina Hund & Gerold SchulerLucie Heinzerling, Anke Hartmann, Martina Hund & Gerold Schuler. 2014. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie
99
142
.
Jui-Ting Yu, Chen-Yu Wang, Youngsen Yang, Ren-Ching Wang, Kuang-Hsi Chang, Wen-Li Hwang & Chieh-Lin Jerry Teng. (2013) Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Annals of Hematology 92:11, pages 1529-1536.
Crossref
Crossref
Sunil Sharma, Joachim Beck, Monica Mita, Sofia Paul, Margaret M. Woo, Margaret Squier, Brian Gadbaw & H. Miles Prince. (2013) A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors. Investigational New Drugs 31:4, pages 974-985.
Crossref
Crossref
Martine BagotT. Petrella & S. Dalle. 2013. Les lymphomes cutanés. Les lymphomes cutanés
133
137
.
Francine Foss, Steven M. Horwitz, Bertrand Coiffier, Nancy Bartlett, Leslie Popplewell, Barbara Pro, Lauren C. Pinter-Brown, Andrei Shustov, Richard R. Furman, Corinne Haioun, Tony Koutsoukos & Owen A. O'Connor. (2012) Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study. Clinical Lymphoma Myeloma and Leukemia 12:4, pages 238-243.
Crossref
Crossref
Matthew J. Matasar & Steven M. Horwitz. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
410
431
.
Donald J. AbrahamMarcia I. Dawson. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
369
546
.
Rudolf Stadler. 2009. Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie
86
94
.
L Marquard, L M Gjerdrum, Ib J Christensen, P B Jensen, M Sehested & E Ralfkiaer. (2008) Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma. Histopathology 53:3, pages 267-277.
Crossref
Crossref
Valeria R. Fantin, Andrey Loboda, Cloud P. Paweletz, Ronald C. Hendrickson, Jacqueline W. Pierce, Jennifer A. Roth, Lixia Li, Frank Gooden, Susan Korenchuk, Xiaoli S. Hou, Elizabeth A. Harrington, Sophia Randolph, John F. Reilly, Christopher M. Ware, Marshall E. Kadin, Stanley R. Frankel & Victoria M. Richon. (2008) Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma. Cancer Research 68:10, pages 3785-3794.
Crossref
Crossref
R. Stadler. (2006) Kutane LymphomeCutaneous lymphomas. Der Hautarzt 57:9, pages 744-755.
Crossref
Crossref
Razelle Kurzrock & Farhad Ravandi. (2006) Purine Analogues in Advanced T-Cell Lymphoid Malignancies. Seminars in Hematology 43, pages S27-S34.
Crossref
Crossref
Che-Leung Law, Kristine A. Gordon, Brian E. Toki, Andrew K. Yamane, Michelle A. Hering, Charles G. Cerveny, Joseph M. Petroziello, Maureen C. Ryan, Leia Smith, Ronald Simon, Guido Sauter, Ezogelin Oflazoglu, Svetlana O. Doronina, Damon L. Meyer, Joseph A. Francisco, Paul Carter, Peter D. Senter, John A. Copland, Christopher G. Wood & Alan F. Wahl. (2006) Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates. Cancer Research 66:4, pages 2328-2337.
Crossref
Crossref
Niko Escher, Bärbel Spies-Weißhart, Martin Kaatz, Christian Melle, Annett Bleul, Dominik Driesch, Uwe Wollina & Ferdinand von Eggeling. (2006) Identification of HNP3 as a tumour marker in CD4+ and CD4− lymphocytes of patients with cutaneous T-cell lymphoma. European Journal of Cancer 42:2, pages 249-255.
Crossref
Crossref